StockData
OPKO Health, Inc. logo

OPKO Health, Inc. (OPK) stock

OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/305% above fair value
$1.62+0.00 (0.00%)

Close on Nov 17, 2026Market cap $1.21BP/E –Yield –

OPKO Health EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

OPKO Health's EV/EBITDA was 16.6× on Apr 29, 2022, against 17.9× a year earlier.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2022Apr 29, 202216.6×+2.5
2021Dec 31, 202114.0×−58.5
2017Jan 31, 201772.6×−5.2
2016Dec 30, 201677.8×–

More OPKO Health figures

See a number that looks wrong?